Form 4 for ERNA Ernexa Therapeutics Inc.
Accepted 2023-06-23 00:00:00 ET · period of report 2023-06-21 · accession 0001140361-23-031258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-23 | 2023-06-21 | ERNA | Gurrola Sandra M | VP of Fin | F - Tax | $2.48 | -179 | 928 | -16% | -$443.92 |
| D | 2023-06-23 | 2023-06-21 | ERNA | Gurrola Sandra M | VP of Fin | M - OptEx | — | +438 | 1,107 | +65% | — |
| D | 2023-06-23 | 2023-06-21 | ERNA | Gurrola Sandra M | VP of Fin | M - OptEx | $0.00 | -438 | 874 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-21 | F | D | 179 | $2.48 | 928 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-21 | M | A | 438 | — | 1,107 | D | — | — | (F1) Each restricted stock unit converts into one share of common stock. |
| 3 | Derivative | Restricted Stock Units | 2023-06-21 | M | D | 438 | $0.00 | 874 | D | — · — to — | 438 Common Stock | (F1) Each restricted stock unit converts into one share of common stock. (F2) On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. |